Shares of Royal Philips have experienced a sharp decline following an announcement from the U.S. Food and Drug Administration (FDA) expressing dissatisfaction with the status of the company's recall of…
Alnylam Pharmaceuticals Inc. (ALNY) shares dropped over 8% in premarket trading on Thursday following the assessment by advisers to the U.S. Food and Drug Administration (FDA) of the company's treatment…
Rocket Pharmaceuticals announced on Tuesday that it has reached alignment with the U.S. Food and Drug Administration (FDA) regarding a trial for its cutting-edge treatment for Danon disease. This significant…
Outlook Therapeutics faced a major setback on Wednesday as the U.S. Food and Drug Administration (FDA) rejected its proposed treatment for wet age-related macular degeneration (AMD). The biopharmaceutical company's shares…
New approvals from the Food and Drug Administration (FDA) are continuing to put downward pressure on the share prices of drug developers, indicating a growing skepticism among investors towards the…
(Humanigen) US Food and Drug Administration has declined to grant an emergency use authorization for Humanigen’s Lenzilumab for use by hospitalized Covid-19 patients. FDA says it is unable to conclusively…
(Bloomberg) US Food and Drug Administration has allowed Moderna Inc., Pfizer Inc., and BioNTech SE vaccines to be given as a third dose to Americans with weak immune systems. The…
The U.S. Food and Drug Administration (FDA) has approved Gilead Sciences Inc.’s Veklury (remdesivir), an antiviral drug for the treatment of patients with COVID19 requiring hospitalization, according to the company’s…